Cadila healthcare informs about press release

04 Mar 2020 Evaluate

Cadila healthcare has informed that the company has enclosed a copy of press release dated March 4, 2020 titled ‘Zydus receives final approval from the USFDA for Emtricitabine and Tenofovir disoproxil Fumarate Tablets 200 mg / 300 mg’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×